MedPath

Clinical Decision Support Algorithm to Predict Diabetic Retinopathy

Conditions
Diabetic Retinopathy
Registration Number
NCT03769948
Lead Sponsor
Oklahoma State University Center for Health Sciences
Brief Summary

Diabetic retinopathy (DR), a complication of diabetes, is a leading cause of blindness among working-aged adults globally. In its early stages, DR is symptomless, and can only be detected by an annual eye exam. Once the disease has progressed to the point where vision loss has occurred, the damage is irreversible. Consequently, early detection is quintessential in treating DR. Two barriers to early detection are poor patient compliance with the annual exam and lack of access to specialists in rural areas. This research is focused on developing and validating new, cost-effective predictive technologies that can improve early screening of DR. Our overall objective is to develop and implement an entire suite of tools to detect diabetes complications in order to augment care for underserved rural populations in the US and internationally.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria

For diabetic patients with DR:

  • With 250.xx diabetes and 362.0x DR ICD-9 codes
  • All variables are complete within the observation window

For diabetic patients without DR:

  • With 250.xx diabetes ICD-9 codes
  • Without 362.0x DR ICD-9 codes
  • All variables are complete within the observation window
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Diabetic retinopathy indicator (yes/no)March, 2019

Diabetic patients with 362.0x ICD-9 codes are classified as DR patient

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath